In one paragraphArticle in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
14 authors.
Ludwig LautenbacherComputational Mass Spectrometry, Technical University of Munich (TUM), Freising, Germany.ORCID 0000-0002-1540-5911 Kevin L YangDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Tobias KockmannFunctional Genomics Center Zurich (FGCZ) - University of Zurich | ETH Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.ORCID 0000-0002-1847-885X Christian PanseFunctional Genomics Center Zurich (FGCZ) - University of Zurich | ETH Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.ORCID 0000-0003-1975-3064 Matthew ChambersDepartment of Genome Sciences, University of Washington, Seattle, WA 98195.
Elias KahlComputational Mass Spectrometry, Technical University of Munich (TUM), Freising, Germany.
Fengchao YuDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-7695-3698 Wassim GabrielComputational Mass Spectrometry, Technical University of Munich (TUM), Freising, Germany.ORCID 0000-0001-6440-9794 Dulguun BoldComputational Mass Spectrometry, Technical University of Munich (TUM), Freising, Germany.
Tobias SchmidtMSAID GmbH, Garching, Germany.
Kai LiDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Alexey I NesvizhskiiDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-2806-7819 Mathias WilhelmComputational Mass Spectrometry, Technical University of Munich (TUM), Freising, Germany.ORCID 0000-0002-9224-3258 Funding
Seattle Quant: A Resource for the Skyline Software EcosystemR24GM141156 · NIGMS · UNIVERSITY OF WASHINGTON · PI Michael MacCoss · 2021 to 2026
$6.7MCOMPUTATIONAL TOOLS FOR MASS SPECTROMETRY-BASED INTERACTOME DATAR01GM094231 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 2010 to 2026
$5.4MMichigan Center for Translational Cancer Proteogenomics-Diversity SupplementU24CA271037 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Saravana Mohan Dhanasekaran, Alexey I Nesvizhskii · 2022 to 2026
$4.4MUniversity of Michigan Proteogenomics Data Analysis CenterU24CA210967 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M, DHANASEKARAN, SARAVANA M · 2016 to 2020
$4.1MProteogenomics of Cancer Training ProgramT32CA140044 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAO, ARVIND, SARTOR, MAUREEN AGNES · 2010 to 2024
$3.9MNCI NIH HHS T32 CA140044NCI NIH HHS U24 CA210967NCI NIH HHS U24 CA271037NIGMS NIH HHS R01 GM094231NIGMS NIH HHS R24 GM141156
6 · The paper itselfAbstract
Recent developments in machine-learning (ML) and deep-learning (DL) have immense potential for applications in proteomics, such as generating spectral libraries, improving peptide identification, and optimizing targeted acquisition modes. Although new ML/DL models for various applications and peptide properties are frequently published, the rate at which these models are adopted by the community is slow, which is mostly due to technical challenges. We believe that, for the community to make better use of state-of-the-art models, more attention should be spent on making models easy to use and accessible by the community. To facilitate this, we developed Koina, an open-source containerized, decentralized and online-accessible high-performance prediction service that enables ML/DL model usage in any pipeline. Using the widely used FragPipe computational platform as example, we show how Koina can be easily integrated with existing proteomics software tools and how these integrations improve data analysis.
Indexed as
AI in life scienceDDAdeep learningdemocratizationDIAFAIRfederatedmachine learningmass spectrometrypeptide property predictionsPRMproteomicsweb service
Identifiers
PMID38895358
PMCPMC11185529
What OpenQuestion holds
Textmetadata
LicenceCC BY-ND
Read underepoch 390